Hello,
I was hoping someone more knowledgeable could weigh in on this and help set my mind at rest.
To give you some context: I'm in my earlyish 30s and I was diagnosed late last year. Treatment's gone about as well as I could've hoped (0.0135% already:).
Anyway, I've probably been reading too much and it's likely a case of don't believe everything you see online, but I'm concerned about the impact nilotinib could have on fathering children.
I was advised by my consultant early on that there no such considerations with TKIs, and that would seem to chime with a few threads here.
However, some articles I've read online would seem to suggest otherwise.
At the foot of this oncolink article on nilotinib, for example, it says: "Exposure of an unborn child to this medication could cause birth defects, so you should not become pregnant or father a child while on this medication."
As another example, cancer.net says: "It is important to note that men and women taking TKIs should avoid fathering a child or becoming pregnant while taking the drugs because of a risk to the developing child."
A third article says there is no data on safety for men on second-generation TKIs, but adds that men are "not recommended to conceive while taking a TKI, with the possible exception of imatinib".
Meanwhile, this PDF on nilotinib, which was produced by the NHS, says: "It is very important the patient understands the potential risk of infertility, all patients should be offered fertility advice. There is a degree of uncertainty but most evidence supports that it is safe to continue nilotinib for male considering partenting. As nilotinib may cause reduced fertility, consider sperm storage/cryopreservation in appropriate patients."
As I understand it, evidence on the subject is relatively thin, but it's hard not to be somewhat alarmed by what I've read because it conflicts with my consultant's initial advice as well as the 2020 ELN recommendations.
Any guidance you could offer would be much appreciated.
Chris